Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark

Table 2 Comparison of resistance rates for E. coli between the National Surveillance program DANMAP and our study

	DANMAP 2014	Our study^a	p-value
Ampicillin	39%	34%	0.19
Sulfamethoxazole	32%	28%	0.2
Trimethoprim	N/A	20%	N/A
Pivmecillinam	5%	4%	0.74
Ciprofloxacin	9%	8%	0.5
Nitrofurantoin	N/A	0	N/A
3rd gen. Cephalosporins + clavulanate^b	4%	4%	0.96

ISSN: 1471-2334